Skip to content

SCHEDULE 13GAccepted May 13, 9:23 PM ET

enGene Therapeutics Inc. SCHEDULE 13G

BML Investment Partners, L.P.

Accepted (ET)

9:23 PM

May 13, 2026

Filed

May 13, 2026

Documents

1

Size

6.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.